Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Target volume motion during anal cancer image guided radiotherapy using cone-beam computed tomography.

Brooks CJ, Bernier L, Hansen VN, Tait DM.

Br J Radiol. 2018 May;91(1085):20170654. doi: 10.1259/bjr.20170654. Epub 2018 Mar 6.

2.

Proposed genitalia contouring guidelines in anal cancer intensity-modulated radiotherapy.

Brooks C, Hansen VN, Riddell A, Harris VA, Tait DM.

Br J Radiol. 2015 Jul;88(1051):20150032. doi: 10.1259/bjr.20150032. Epub 2015 May 8.

3.

Pelvic Intensity-modulated Radiotherapy: Can we Better Quantify the Late Side-effects?

De Francesco I, Thomas K, Tait DM.

Clin Oncol (R Coll Radiol). 2015 Jul;27(7):428. doi: 10.1016/j.clon.2015.02.004. Epub 2015 Feb 26. No abstract available.

PMID:
25727647
4.

Cardiac volume effects during chemoradiotherapy for esophageal cancer (Regarding Lutkenhaus et al. Reduction in cardiac volume during chemoradiotherapy for patients with esophageal cancer).

Edmunds K, Brooks C, Hansen VN, Harris V, Tait DM.

Radiother Oncol. 2015 Jan;114(1):128-9. doi: 10.1016/j.radonc.2014.11.041. Epub 2014 Dec 10. No abstract available.

PMID:
25497875
5.

Magnetic resonance imaging defined mucinous rectal carcinoma is an independent imaging biomarker for poor prognosis and poor response to preoperative chemoradiotherapy.

Yu SK, Chand M, Tait DM, Brown G.

Eur J Cancer. 2014 Mar;50(5):920-7. doi: 10.1016/j.ejca.2013.12.007. Epub 2014 Jan 15.

PMID:
24440086
6.

Chemoradiotherapy response in recurrent rectal cancer.

Yu SK, Bhangu A, Tait DM, Tekkis P, Wotherspoon A, Brown G.

Cancer Med. 2014 Feb;3(1):111-7. doi: 10.1002/cam4.169. Epub 2013 Dec 16.

7.

Risk-adapted strategy partial liver irradiation for the treatment of large volume metastatic liver disease.

Aitken KL, Tait DM, Nutting CM, Khabra K, Hawkins MA.

Acta Oncol. 2014 May;53(5):702-6. doi: 10.3109/0284186X.2013.862595. Epub 2013 Dec 9. No abstract available.

PMID:
24313391
8.

Normal tissue sparing with respiratory adapted volumetric modulated arc therapy for distal oesophageal and gastro-oesophageal tumours.

Hafeez S, Bedford JL, Tait DM, Hawkins MA.

Acta Oncol. 2014 Jan;53(1):149-54. doi: 10.3109/0284186X.2013.776174. Epub 2013 Mar 21. No abstract available.

PMID:
23517249
9.

A solitary bone lesion in a patient with previous breast cancer and the importance of bone biopsy: a case report and a review of guidelines.

Schiavon G, Tait DM, Briggs TW, Smith IE.

Clin Breast Cancer. 2013 Feb;13(1):77-80. doi: 10.1016/j.clbc.2012.10.004. Epub 2012 Nov 29. No abstract available.

PMID:
23199805
10.

Organ-sparing Intensity-modulated radiotherapy for anal cancer using the ACTII schedule: a comparison of conventional and intensity-modulated radiotherapy plans.

Brooks CJ, Lee YK, Aitken K, Hansen VN, Tait DM, Hawkins MA.

Clin Oncol (R Coll Radiol). 2013 Mar;25(3):155-61. doi: 10.1016/j.clon.2012.08.008. Epub 2012 Sep 14.

PMID:
22981970
11.

Cone beam CT verification for oesophageal cancer - impact of volume selected for image registration.

Hawkins MA, Aitken A, Hansen VN, McNair HA, Tait DM.

Acta Oncol. 2011 Nov;50(8):1183-90. doi: 10.3109/0284186X.2011.572912. Epub 2011 Apr 15.

PMID:
21495791
12.

Volumetric modulated arc therapy planning for distal oesophageal malignancies.

Hawkins MA, Bedford JL, Warrington AP, Tait DM.

Br J Radiol. 2012 Jan;85(1009):44-52. doi: 10.1259/bjr/25428720. Epub 2011 Mar 22.

13.

Set-up errors in radiotherapy for oesophageal cancers--is electronic portal imaging or conebeam more accurate?

Hawkins MA, Aitken A, Hansen VN, McNair HA, Tait DM.

Radiother Oncol. 2011 Feb;98(2):249-54. doi: 10.1016/j.radonc.2010.11.002. Epub 2010 Dec 6.

PMID:
21144607
14.

Spectral domain optical coherence tomography and adaptive optics: imaging photoreceptor layer morphology to interpret preclinical phenotypes.

Rha J, Dubis AM, Wagner-Schuman M, Tait DM, Godara P, Schroeder B, Stepien K, Carroll J.

Adv Exp Med Biol. 2010;664:309-16. doi: 10.1007/978-1-4419-1399-9_35.

15.

Arrested development: high-resolution imaging of foveal morphology in albinism.

McAllister JT, Dubis AM, Tait DM, Ostler S, Rha J, Stepien KE, Summers CG, Carroll J.

Vision Res. 2010 Apr 7;50(8):810-7. doi: 10.1016/j.visres.2010.02.003. Epub 2010 Feb 10.

16.

Unusual adaptive optics findings in a patient with bilateral maculopathy.

Godara P, Rha J, Tait DM, McAllister J, Dubis A, Carroll J, Weinberg DV.

Arch Ophthalmol. 2010 Feb;128(2):253-4. doi: 10.1001/archophthalmol.2009.383. No abstract available.

17.

Cone photoreceptor mosaic disruption associated with Cys203Arg mutation in the M-cone opsin.

Carroll J, Baraas RC, Wagner-Schuman M, Rha J, Siebe CA, Sloan C, Tait DM, Thompson S, Morgan JI, Neitz J, Williams DR, Foster DH, Neitz M.

Proc Natl Acad Sci U S A. 2009 Dec 8;106(49):20948-53. doi: 10.1073/pnas.0910128106. Epub 2009 Nov 23.

18.

Cone beam computed tomography-derived adaptive radiotherapy for radical treatment of esophageal cancer.

Hawkins MA, Brooks C, Hansen VN, Aitken A, Tait DM.

Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):378-83. doi: 10.1016/j.ijrobp.2009.05.045. Epub 2009 Sep 21.

PMID:
19775828
19.

Retinal imaging using commercial broadband optical coherence tomography.

Tanna H, Dubis AM, Ayub N, Tait DM, Rha J, Stepien KE, Carroll J.

Br J Ophthalmol. 2010 Mar;94(3):372-6. doi: 10.1136/bjo.2009.163501. Epub 2009 Sep 21.

20.

Normality of colour vision in a compound heterozygous female carrying protan and deutan defects.

Tait DM, Carroll J.

Clin Exp Optom. 2009 Jul;92(4):356-61. doi: 10.1111/j.1444-0938.2009.00359.x. Epub 2009 Mar 17.

21.

The effect of treatment position, prone or supine, on dose-volume histograms for pelvic radiotherapy in patients with rectal cancer.

Drzymala M, Hawkins MA, Henrys AJ, Bedford J, Norman A, Tait DM.

Br J Radiol. 2009 Apr;82(976):321-7. doi: 10.1259/bjr/57848689. Epub 2009 Feb 2.

PMID:
19188240
22.

MR vs CT imaging: low rectal cancer tumour delineation for three-dimensional conformal radiotherapy.

O'Neill BD, Salerno G, Thomas K, Tait DM, Brown G.

Br J Radiol. 2009 Jun;82(978):509-13. doi: 10.1259/bjr/60198873. Epub 2009 Jan 19.

PMID:
19153180
23.

Topography of the long- to middle-wavelength sensitive cone ratio in the human retina assessed with a wide-field color multifocal electroretinogram.

Kuchenbecker JA, Sahay M, Tait DM, Neitz M, Neitz J.

Vis Neurosci. 2008 May-Jun;25(3):301-6. doi: 10.1017/S0952523808080474.

24.

Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer.

O'Neill BD, Brown G, Heald RJ, Cunningham D, Tait DM.

Lancet Oncol. 2007 Jul;8(7):625-33. Review.

PMID:
17613424
25.

MRI in predicting curative resection of rectal cancer: new dilemma in multidisciplinary team management.

Heald RJ, O'Neill BD, Moran B, Brown G, Darzi AW, Wotherspoon AC, Cunningham D, Tait DM.

BMJ. 2006 Oct 14;333(7572):808. No abstract available.

26.

Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels.

Guerrero Urbano MT, Henrys AJ, Adams EJ, Norman AR, Bedford JL, Harrington KJ, Nutting CM, Dearnaley DP, Tait DM.

Int J Radiat Oncol Biol Phys. 2006 Jul 1;65(3):907-16.

PMID:
16751073
27.

Consent for investigating and treating adults with cancer.

Tait DM, Hardy J.

Clin Oncol (R Coll Radiol). 2006 Feb;18(1):23-9.

PMID:
16477916
28.

Multi-modality treatment in oesophageal cancer: a curse for radiotherapy progress.

Tait DM.

Radiother Oncol. 2004 Nov;73(2):115-7. No abstract available.

PMID:
15542157
29.

Evaluation of an updated HRR color vision test.

Bailey JE, Neitz M, Tait DM, Neitz J.

Vis Neurosci. 2004 May-Jun;21(3):431-6.

PMID:
15518225
30.

Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma.

Taylor RE, Bailey CC, Robinson KJ, Weston CL, Ellison D, Ironside J, Lucraft H, Gilbertson R, Tait DM, Saran F, Walker DA, Pizer BL, Lashford LS; United Kingdom Children's Cancer Study Group Brain Tumour Committee; International Society of Paediatric Oncology.

Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1184-93.

PMID:
15001263
31.

Can the irradiated uterus sustain a pregnancy? A literature review.

Urbano MT, Tait DM.

Clin Oncol (R Coll Radiol). 2004 Feb;16(1):24-8. Review.

PMID:
14768752
32.

Molecular pharmacology of cancer therapy in human colorectal cancer by gene expression profiling.

Clarke PA, George ML, Easdale S, Cunningham D, Swift RI, Hill ME, Tait DM, Workman P.

Cancer Res. 2003 Oct 15;63(20):6855-63.

33.

Adjuvant therapy in pancreatic cancer: historical and current perspectives.

Neoptolemos JP, Cunningham D, Friess H, Bassi C, Stocken DD, Tait DM, Dunn JA, Dervenis C, Lacaine F, Hickey H, Raraty MG, Ghaneh P, B├╝chler MW.

Ann Oncol. 2003 May;14(5):675-92. Review.

PMID:
12702520
34.

Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study.

Taylor RE, Bailey CC, Robinson K, Weston CL, Ellison D, Ironside J, Lucraft H, Gilbertson R, Tait DM, Walker DA, Pizer BL, Imeson J, Lashford LS; International Society of Paediatric Oncology; United Kingdom Children's Cancer Study Group.

J Clin Oncol. 2003 Apr 15;21(8):1581-91.

PMID:
12697884
35.

Intensity-modulated radiotherapy reduces lung irradiation in patients with carcinoma of the oesophagus.

Nutting CM, Bedford JL, Cosgrove VP, Tait DM, Dearnaley DP, Webb S.

Front Radiat Ther Oncol. 2002;37:128-31. No abstract available.

PMID:
11764654
36.

Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer.

George ML, Dzik-Jurasz AS, Padhani AR, Brown G, Tait DM, Eccles SA, Swift RI.

Br J Surg. 2001 Dec;88(12):1628-36.

PMID:
11736977
37.

A comparison of conformal and intensity-modulated techniques for oesophageal radiotherapy.

Nutting CM, Bedford JL, Cosgrove VP, Tait DM, Dearnaley DP, Webb S.

Radiother Oncol. 2001 Nov;61(2):157-63.

PMID:
11690681
38.

A quantitative treatment planning study evaluating the potential of dose escalation in conformal radiotherapy of the oesophagus.

Bedford JL, Viviers L, Guzel Z, Childs PJ, Webb S, Tait DM.

Radiother Oncol. 2000 Nov;57(2):183-93.

PMID:
11054522
39.

Proton magnetic resonance spectroscopy ((1)H-MRS) of the brain following high-dose methotrexate treatment for childhood cancer.

Davidson A, Payne G, Leach MO, McVicar D, Britton JM, Watson M, Tait DM.

Med Pediatr Oncol. 2000 Jul;35(1):28-34.

PMID:
10881004
40.

Magnetic resonance spectroscopy in the evaluation of neurotoxicity following cranial irradiation for childhood cancer.

Davidson A, Tait DM, Payne GS, Hopewell JW, Leach MO, Watson M, MacVicar AD, Britton JA, Ashley S.

Br J Radiol. 2000 Apr;73(868):421-4.

PMID:
10844868
41.

Local radiotherapy for alveolar air leak.

Kanagasabay RR, Lamb PM, Tait DM, Madden BP.

J R Soc Med. 1999 Apr;92(4):190-2. No abstract available.

42.

Management of colorectal cancer: haematology.

Tait DM.

Crit Rev Oncol Hematol. 1999 May;30(3):207-14. Review. No abstract available.

PMID:
10439066
43.

Verification systems--tools or toys?

Tait DM.

Br J Radiol. 1998 Jun;71(846):581-3. No abstract available.

PMID:
9849378
44.
45.

Acute toxicity in pelvic radiotherapy; a randomised trial of conformal versus conventional treatment.

Tait DM, Nahum AE, Meyer LC, Law M, Dearnaley DP, Horwich A, Mayles WP, Yarnold JR.

Radiother Oncol. 1997 Feb;42(2):121-36.

PMID:
9106921
46.

Radiotherapy and adjuvant chemotherapy for childhood medulloblastoma. The Royal Marsden Hospital experience.

Whitton AC, Syndikus I, Tait DM, Bloom HJ.

Strahlenther Onkol. 1995 Nov;171(11):615-21.

PMID:
7502224
47.
48.

Cellular sensitivity and low dose-rate recovery in Fanconi anaemia fibroblasts.

Burnet NG, Wurm R, Tait DM, Peacock JH.

Br J Radiol. 1994 Jun;67(798):579-83.

PMID:
8032812
50.

The Royal Marsden Hospital pelvic radiotherapy trial: technical aspects and quality assurance.

Mayles WP, Chow M, Dyer J, Fernandez EM, Heisig S, Knight RT, Moore I, Nahum AE, Shentall GS, Tait DM.

Radiother Oncol. 1993 Nov;29(2):184-91.

PMID:
8310144

Supplemental Content

Support Center